Study on establishment of screening method for sarcopenia in patients with cardiovascular risk and its application to risk stratification of cardiovascular event.
Not Applicable
- Conditions
- cardiovascular disease
- Registration Number
- JPRN-UMIN000044006
- Lead Sponsor
- Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 1218
Inclusion Criteria
Not provided
Exclusion Criteria
Nothing
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Composite of cardiovascular events
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways link sarcopenia to cardiovascular event risk in high-risk patients?
How does the new sarcopenia screening method compare to existing cardiovascular risk stratification tools?
Which biomarkers predict cardiovascular event risk in sarcopenic patients with atherosclerosis?
What adverse outcomes are associated with sarcopenia in JPRN-UMIN000044006 cardiovascular disease patients?
How can sarcopenia screening improve treatment strategies for heart failure patients with metabolic syndrome?